The Venture Codex Logo

The Venture Codex

Overview

Clinical-stage biopharmaceutical company specializing in radiopharmaceutica

Total Raised

$171 M

Rounds

4

Links

Verticals

Biopharma
Biotechnology
Medical
Oncology
Pharmaceutical

Investment History

  1. Equity

    Jan 2020

    $20M

  2. Series B

    Apr 2019

    $105M

  3. Series A

    Sep 2017

    $21M

  4. Series A

    Feb 2017

    $25M

Team

John Valliant

Founder and Chief Executive Officer

Maria Stahl

Chief Legal Officer

Dmitri Bobilev

Chief Medical Officer

Chris Leamon

Chief Scientific Officer